Siegfried Holding AG's EBIT per Share for the
six
months ended in Dec. 2025 was CHF2.98.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 was CHF4.91.
During the past 12 months, the average EBIT per Share Growth Rate of Siegfried Holding AG was 9.40% per year.
During the past 3 years, the average EBIT per Share Growth Rate was -2.40% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 18.00% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 18.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Siegfried Holding AG's EBIT per Share or its related term are showing as below:
XSWX:SFZN'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -60 Med: 7.2 Max: 81.7
Current: -2.4
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Siegfried Holding AG was 81.70% per year. The lowest was -60.00% per year. And the median was 7.20% per year.
XSWX:SFZN's 3-Year EBIT Growth Rate is ranked worse than 64.98% of 811
companies
in the Drug Manufacturers industry
Industry Median: 7.8
vs XSWX:SFZN: -2.40
Siegfried Holding AG (XSWX:SFZN) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Siegfried Holding AG EBIT per Share Related Terms
Siegfried Holding AG EBIT per Share Historical Data
* Premium members only.
The historical data trend for Siegfried Holding AG's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF4.91
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Siegfried Holding AG (XSWX:SFZN) has a EBIT per Share of CHF4.91 as of Dec. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Siegfried Holding AG and its competitors. According to the industry distribution chart, Siegfried Holding AG ranks #527 out of 811 companies in the Drug Manufacturers industry, placing it in the top 65%.
Is Siegfried Holding AG's EBIT per Share too high?
Siegfried Holding AG's current EBIT per Share is CHF4.91. Based on the distribution chart, Siegfried Holding AG ranks #527 out of 811 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Siegfried Holding AG has a GF Score™ of 95/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Siegfried Holding AG's EBIT per Share compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Siegfried Holding AG ranks #527 out of 811 companies for EBIT per Share. This places Siegfried Holding AG in the lower half of its industry. The industry median EBIT per Share is 7.80. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Drug Manufacturers company?
The median EBIT per Share among Drug Manufacturers companies is 7.80, based on 811 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Siegfried Holding AG and its competitors. For the Drug Manufacturers industry, the median EBIT per Share is 7.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Siegfried Holding AG's current EBIT per Share is CHF4.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Siegfried Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Siegfried Holding AG (XSWX:SFZN) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF92.05, compared to a current price of CHF71.80 — trading 22% below its estimated fair value. The current EBIT per Share is CHF4.91. Siegfried Holding AG's overall GF Score™ is 95/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Siegfried Holding AG (XSWX:SFZN), the current EBIT per Share is CHF4.91 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Siegfried Holding AG (XSWX:SFZN) Overvalued in 2026?
Based on GuruFocus' analysis, Siegfried Holding AG stock appears to be undervalued.
The current stock price of CHF71.80 is trading 22% below its estimated GF Value™ of CHF92.05.
GuruFocus considers Siegfried Holding AG to be Modestly Undervalued.
Key valuation signals for XSWX:SFZN:
EBIT per Share: CHF4.91
GF Value™: CHF92.05 vs. price of CHF71.80 (22% below fair value)
No single metric tells the full story. See the XSWX:SFZN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Siegfried is a global contract development and manufacturing organization. It derives its revenue primarily from long-term supply agreements with biotechnology and pharmaceutical customers. Siegfried develops and manufactures active pharmaceutical ingredients, finished dosage forms (tablets, capsules, sterile vials, ampules, cartridges, and ointments), and viral vectors. The company provides these services throughout the entire drug lifecycle, including chemical and analytical development, pilot manufacturing, and commercial-scale manufacturing. Siegfried has a large global footprint with 13 production sites on three continents.
95GF Score
Get the complete analysis for XSWX:SFZN
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:SFZN has been successfully added to your 
